Jeff Baxter, VBI Vaccines CEO (ChromaDex)
VBI Vaccines execs tout approval of new triple-antigen hepatitis B shot. Can they sell it?
VBI Vaccines celebrated a new approval Wednesday morning, announcing the FDA has greenlighted its hepatitis B vaccine for adults. But questions remain on how well …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.